SeqLL Information
Contact top employees from
SeqLL
Summary
SeqLL is a public company that has been in the industry for 13 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the CEO is occupied by Elizabeth Reczek. Its headquarters is located at Woburn, Massachusetts, USA. The estimated number of employees - 8. The SeqLL annual revenue is estimated at < 1M. Total funding of the company - $28.5M. To connect with SeqLL employee register on SignalHire.
Organization Website | SeqLL.com |
Social Links |    |
Phone Number | 781-460-6016 |
Industries | |
Headquarters Location | 317 New Boston Street, Suite #210, Woburn, MA, 01801 US |
Employees Size | 1-10 employees |
Specialties | Genetic Sequencing, RNAseq/cDNA, DRS, true Single Molecule Sequencing (tSMS) |
SIC Code | 2836 |
DMA Code | Greater Boston |
Founded | 2013 |
Operating Status | Independent Company |
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2013 | Privately Held | 250 - 500 | 20.3M | $135.5M | |
| 2004 | Privately Held | 500 - 1.0K | 68.3M | $1.3B | |
| 2010 | Privately Held | 100 - 250 | 6.3M | $342.2M | |
| 2008 | Privately Held | 25 - 100 | 2.1M | $17.1M |
Employees Turnover 4 quarter 2025
Length of Employment
Employee tenure at SeqLL shows a diverse range of experience levels:
17% for 1–2 years8% for 3–4 years17% for 5–7 years33% for 8–10 years25% have over 11 years of service at SeqLLContact top employees from
SeqLL
Elizabeth Fournier
Technical Sales Manager, North America
Brian Paras
Chief Business Officer
Jiaren Zhang
Bioinformatics Scientist
Similar Companies
FAQ
SeqLL operates in the Biotech industries. More details can be found on the official website: SeqLL.com.
The headquarters of SeqLL are located in Woburn, United States.
The current CEO of SeqLL is Elizabeth Reczek
You can contact SeqLL by phone at 781-460-6016.
SeqLL currently employs 1-10 people.
SeqLL's revenue is approximately < 1M.
Well-known competitors of SeqLL include MEDGENOME, Oxford Nanopore Technologies, Genapsys and Eagle Genomics.
